-

02:16:44 AM

ABT Stock News

ABT - Abbott Laboratories

02/01/23 9:30 AM

NYSE : ABT

partnership

The Partnerships Changing How You Manage Diabetes

Abbott Abbott Go ahead, call it a comeback. There's new energy around connecting - whether among people or technologies - thanks to the not-so-distant pandemic lockdowns that reminded the world why relationships matter. This comes as Abbott's

RHEA-AI

neutral

01/26/23 9:00 AM

NYSE : ABT

fda approval

FDA Approves Abbott's Spinal Cord Stimulation for People Living with Painful Diabetic Peripheral Neuropathy

The new indication for Abbott's Proclaim™ XR SCS system provides a non-medication option for people with painful diabetic peripheral neuropathy Spinal cord stimulation is proven to be more effective than conventional medical management in the treatment of chronic pain 1,2 ABBOTT PARK, Ill., Jan.

RHEA-AI

neutral

01/25/23 7:30 AM

NYSE : ABT

Abbott Reports Fourth-Quarter and Full-Year 2022 Results; Issues 2023 Financial Outlook

Abbott today announced financial results for the fourth quarter ended Dec. 31, 2022. Excluding specified items, adjusted diluted EPS was $1.03. Abbott issues full-year 2023 guidance for diluted EPS from continuing operations on a GAAP basis of $3.05 to $3.25 and full-year adjusted EPS from continuing operations of...

RHEA-AI

neutral

01/23/23 9:30 AM

NYSE : ABT

Abbott, Blood Centers of America Launch First-of-Its-Kind Mixed Reality Experience for Use During Blood Donation

Mixed reality offers donors an innovative, immersive digital experience while giving blood The Abbott technology is one of the first-ever, consumer-focused mixed reality applications completely controlled through eye tracking Innovation aims to improve the experience and attract new, younger blood

RHEA-AI

positive

01/17/23 9:00 AM

NYSE : ABT

fda approval

Abbott Receives FDA Approval for Navitor™, a Next-Generation TAVI System Designed to Treat Aortic Stenosis

Abbott's new Navitor device features advancements to improve patient care, including reducing or eliminating risk of blood leakage around valve implant Transcatheter aortic valve implantation (TAVI) offers minimally invasive alternative to surgery for people with aortic stenosis, a common and

RHEA-AI

positive

01/09/23 7:30 PM

AMEX, NYSE : RMED, MDT, ABT

acquisitionlow float

Ra Medical Systems Completes Merger with Catheter Precision

Ra Medical Systems, Inc. announces the completion of its previously announced stock-for-stock merger transaction with Catheter Precision, Inc., a company focused on the cardiac electrophysiology market. Mr. Jenkins was instrumental in operating several medical device startups, including Transneuronix, Inc., which was...

RHEA-AI

neutral

01/06/23 9:00 PM

NYSE : ABT

Abbott, Blood Centers of America Launch First-of-its-Kind Mixed Reality Experience for Use During Blood Donation

Mixed reality offers donors an innovative, immersive digital experience while giving blood The Abbott technology is one of the first-ever, consumer-focused mixed reality applications completely controlled through eye tracking Innovation aims to improve the experience and attract new, younger blood

RHEA-AI

positive

01/04/23 9:00 AM

NYSE : ABT

earnings

Abbott Hosts Conference Call for Fourth-Quarter Earnings

Abbott (NYSE: ABT) will announce its fourth-quarter 2022 financial results on Wednesday, Jan. 25, 2023, before the market opens.The announcement will be followed by a live webcast of the earnings conference call at 8 a.m. Central time ( 9 a.m.

RHEA-AI

neutral

12/21/22 9:00 AM

NYSE : ABT

Abbott's FreeStyle Libre® 3 Integrated with Automated Insulin Delivery System mylife™ Loop in Germany

First automated insulin delivery (AID) system in the world to work with Abbott's FreeStyle Libre ® 3 sensor Automated process streamlines and improves daily diabetes management for people who are on insulin therapy 1 Hybrid closed-loop system mylife ™ Loop incorporates technology from two partners:

RHEA-AI

neutral

12/20/22 9:00 AM

NYSE : ABT

conferences

Abbott to Present at J.P. Morgan Healthcare Conference

Abbott (NYSE: ABT) will present at the 41 st Annual J.P. Morgan Healthcare Conference on Tuesday, Jan. 10, 2023. Robert B. Ford, chairman and chief executive officer, will present at 11 a.m. Central time.A live webcast of the presentation will be

RHEA-AI

neutral

1 2 3 4 5 6 7 8 9 10 Next